25 XP   0   0   10

Getein Biotech Inc
Buy, Hold or Sell?

Let's analyse Getein together

PenkeI guess you are interested in Getein Biotech Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Getein Biotech Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Getein Biotech Inc

I send you an email if I find something interesting about Getein Biotech Inc.

Quick analysis of Getein (30 sec.)










What can you expect buying and holding a share of Getein? (30 sec.)

How much money do you get?

How much money do you get?
¥0.15
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.25
Expected worth in 1 year
¥8.33
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥4.19
Return On Investment
48.0%

For what price can you sell your share?

Current Price per Share
¥8.73
Expected price per share
¥7.44 - ¥9.56
How sure are you?
50%

1. Valuation of Getein (5 min.)




Live pricePrice per Share (EOD)

¥8.73

Intrinsic Value Per Share

¥4.19 - ¥8.16

Total Value Per Share

¥9.45 - ¥13.41

2. Growth of Getein (5 min.)




Is Getein growing?

Current yearPrevious yearGrowGrow %
How rich?$367.9m$314m$53.9m14.7%

How much money is Getein making?

Current yearPrevious yearGrowGrow %
Making money$68.8m$55.1m$13.7m20.0%
Net Profit Margin27.4%28.5%--

How much money comes from the company's main activities?

3. Financial Health of Getein (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#73 / 336

Most Revenue
#49 / 336

Most Profit
#23 / 336

What can you expect buying and holding a share of Getein? (5 min.)

Welcome investor! Getein's management wants to use your money to grow the business. In return you get a share of Getein.

What can you expect buying and holding a share of Getein?

First you should know what it really means to hold a share of Getein. And how you can make/lose money.

Speculation

The Price per Share of Getein is ¥8.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Getein.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Getein, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.25. Based on the TTM, the Book Value Change Per Share is ¥0.77 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.28 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Getein.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.141.6%0.141.6%0.111.2%0.101.1%0.060.7%
Usd Book Value Change Per Share0.111.2%0.111.2%0.070.8%0.080.9%0.080.9%
Usd Dividend Per Share0.040.4%0.040.4%0.030.3%0.030.3%0.020.2%
Usd Total Gains Per Share0.141.7%0.141.7%0.101.2%0.111.3%0.101.1%
Usd Price Per Share1.73-1.73-2.77-3.22-2.71-
Price to Earnings Ratio12.71-12.71-25.50-36.71-37.82-
Price-to-Total Gains Ratio11.93-11.93-27.23-31.10-31.72-
Price to Book Ratio2.38-2.38-4.47-6.44-6.52-
Price-to-Total Gains Ratio11.93-11.93-27.23-31.10-31.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.205613
Number of shares829
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.110.08
Usd Total Gains Per Share0.140.11
Gains per Quarter (829 shares)119.9490.96
Gains per Year (829 shares)479.74363.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
112735347090274354
2254705950180548718
3381105814302708221082
45081411191036010961446
56351763239044913701810
67622116287053916442174
78902469335062919182538
810172821383071921912902
911443174431080924653266
1012713527479089927393630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.02.077.8%7.00.03.070.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%10.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.01.090.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%10.00.00.0100.0%

Fundamentals of Getein

About Getein Biotech Inc

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China.

Fundamental data was last updated by Penke on 2024-04-18 12:37:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Getein Biotech Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Getein earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Getein to the Medical Devices industry mean.
  • A Net Profit Margin of 27.4% means that ¥0.27 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Getein Biotech Inc:

  • The MRQ is 27.4%. The company is making a huge profit. +2
  • The TTM is 27.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ27.4%TTM27.4%0.0%
TTM27.4%YOY28.5%-1.1%
TTM27.4%5Y30.9%-3.5%
5Y30.9%10Y25.7%+5.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ27.4%-11.2%+38.6%
TTM27.4%-18.9%+46.3%
YOY28.5%-13.9%+42.4%
5Y30.9%-21.0%+51.9%
10Y25.7%-24.6%+50.3%
1.1.2. Return on Assets

Shows how efficient Getein is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Getein to the Medical Devices industry mean.
  • 13.6% Return on Assets means that Getein generated ¥0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Getein Biotech Inc:

  • The MRQ is 13.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 13.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.6%TTM13.6%0.0%
TTM13.6%YOY12.7%+0.9%
TTM13.6%5Y14.1%-0.5%
5Y14.1%10Y13.1%+1.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ13.6%-4.0%+17.6%
TTM13.6%-4.6%+18.2%
YOY12.7%-4.4%+17.1%
5Y14.1%-3.9%+18.0%
10Y13.1%-4.9%+18.0%
1.1.3. Return on Equity

Shows how efficient Getein is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Getein to the Medical Devices industry mean.
  • 20.1% Return on Equity means Getein generated ¥0.20 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Getein Biotech Inc:

  • The MRQ is 20.1%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.1%TTM20.1%0.0%
TTM20.1%YOY18.9%+1.2%
TTM20.1%5Y19.0%+1.1%
5Y19.0%10Y17.0%+2.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.1%-4.1%+24.2%
TTM20.1%-5.7%+25.8%
YOY18.9%-5.5%+24.4%
5Y19.0%-6.0%+25.0%
10Y17.0%-6.9%+23.9%

1.2. Operating Efficiency of Getein Biotech Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Getein is operating .

  • Measures how much profit Getein makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Getein to the Medical Devices industry mean.
  • An Operating Margin of 30.5% means the company generated ¥0.30  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Getein Biotech Inc:

  • The MRQ is 30.5%. The company is operating very efficient. +2
  • The TTM is 30.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.5%TTM30.5%0.0%
TTM30.5%YOY31.1%-0.7%
TTM30.5%5Y31.9%-1.4%
5Y31.9%10Y27.2%+4.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ30.5%-24.1%+54.6%
TTM30.5%-16.7%+47.2%
YOY31.1%-12.5%+43.6%
5Y31.9%-19.0%+50.9%
10Y27.2%-23.8%+51.0%
1.2.2. Operating Ratio

Measures how efficient Getein is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are ¥1.04 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Getein Biotech Inc:

  • The MRQ is 1.045. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.045. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.045TTM1.0450.000
TTM1.045YOY1.033+0.012
TTM1.0455Y0.973+0.072
5Y0.97310Y0.743+0.230
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0451.431-0.386
TTM1.0451.426-0.381
YOY1.0331.435-0.402
5Y0.9731.436-0.463
10Y0.7431.373-0.630

1.3. Liquidity of Getein Biotech Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Getein is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.50 means the company has ¥2.50 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Getein Biotech Inc:

  • The MRQ is 2.504. The company is able to pay all its short-term debts. +1
  • The TTM is 2.504. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.504TTM2.5040.000
TTM2.504YOY2.908-0.403
TTM2.5045Y4.141-1.637
5Y4.14110Y3.709+0.432
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5042.726-0.222
TTM2.5042.732-0.228
YOY2.9083.496-0.588
5Y4.1413.560+0.581
10Y3.7093.507+0.202
1.3.2. Quick Ratio

Measures if Getein is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Getein to the Medical Devices industry mean.
  • A Quick Ratio of 1.05 means the company can pay off ¥1.05 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Getein Biotech Inc:

  • The MRQ is 1.049. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.049. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.0490.000
TTM1.049YOY1.293-0.243
TTM1.0495Y1.343-0.294
5Y1.34310Y1.745-0.402
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0491.527-0.478
TTM1.0491.645-0.596
YOY1.2932.113-0.820
5Y1.3432.289-0.946
10Y1.7452.245-0.500

1.4. Solvency of Getein Biotech Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Getein assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Getein to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.28 means that Getein assets are financed with 27.5% credit (debt) and the remaining percentage (100% - 27.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Getein Biotech Inc:

  • The MRQ is 0.275. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.275. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.2750.000
TTM0.275YOY0.275+0.000
TTM0.2755Y0.218+0.057
5Y0.21810Y0.228-0.010
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.393-0.118
TTM0.2750.386-0.111
YOY0.2750.337-0.062
5Y0.2180.442-0.224
10Y0.2280.461-0.233
1.4.2. Debt to Equity Ratio

Measures if Getein is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Getein to the Medical Devices industry mean.
  • A Debt to Equity ratio of 40.8% means that company has ¥0.41 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Getein Biotech Inc:

  • The MRQ is 0.408. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.408. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.408TTM0.4080.000
TTM0.408YOY0.410-0.002
TTM0.4085Y0.307+0.101
5Y0.30710Y0.333-0.026
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4080.560-0.152
TTM0.4080.560-0.152
YOY0.4100.479-0.069
5Y0.3070.625-0.318
10Y0.3330.676-0.343

2. Market Valuation of Getein Biotech Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Getein generates.

  • Above 15 is considered overpriced but always compare Getein to the Medical Devices industry mean.
  • A PE ratio of 12.71 means the investor is paying ¥12.71 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Getein Biotech Inc:

  • The EOD is 8.874. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.707. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.707. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD8.874MRQ12.707-3.832
MRQ12.707TTM12.7070.000
TTM12.707YOY25.498-12.792
TTM12.7075Y36.714-24.008
5Y36.71410Y37.820-1.106
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD8.874-0.992+9.866
MRQ12.707-1.592+14.299
TTM12.707-2.128+14.835
YOY25.498-2.756+28.254
5Y36.714-2.086+38.800
10Y37.820-1.490+39.310
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Getein Biotech Inc:

  • The EOD is 16.675. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.876. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 23.876. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.675MRQ23.876-7.201
MRQ23.876TTM23.8760.000
TTM23.876YOY40.248-16.372
TTM23.8765Y119.553-95.677
5Y119.55310Y92.306+27.248
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD16.675-0.936+17.611
MRQ23.876-1.487+25.363
TTM23.876-2.933+26.809
YOY40.248-6.215+46.463
5Y119.553-4.622+124.175
10Y92.306-4.718+97.024
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Getein is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.38 means the investor is paying ¥2.38 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Getein Biotech Inc:

  • The EOD is 1.662. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.379. Based on the equity, the company is underpriced. +1
  • The TTM is 2.379. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.662MRQ2.379-0.718
MRQ2.379TTM2.3790.000
TTM2.379YOY4.474-2.095
TTM2.3795Y6.442-4.063
5Y6.44210Y6.524-0.082
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.6621.923-0.261
MRQ2.3792.377+0.002
TTM2.3792.451-0.072
YOY4.4743.215+1.259
5Y6.4423.862+2.580
10Y6.5244.187+2.337
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Getein Biotech Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7700.7700%0.532+45%0.598+29%0.575+34%
Book Value Per Share--5.2545.2540%4.484+17%3.947+33%2.574+104%
Current Ratio--2.5042.5040%2.908-14%4.141-40%3.709-32%
Debt To Asset Ratio--0.2750.2750%0.275+0%0.218+26%0.228+21%
Debt To Equity Ratio--0.4080.4080%0.410-1%0.307+33%0.333+22%
Dividend Per Share--0.2770.2770%0.204+36%0.196+41%0.144+93%
Eps--0.9840.9840%0.787+25%0.707+39%0.465+111%
Free Cash Flow Per Share--0.5240.5240%0.498+5%0.303+73%0.239+119%
Free Cash Flow To Equity Per Share--0.4330.4330%0.441-2%0.362+20%0.404+7%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.778+29%
Intrinsic Value_10Y_max--8.160--------
Intrinsic Value_10Y_min--4.195--------
Intrinsic Value_1Y_max--0.482--------
Intrinsic Value_1Y_min--0.336--------
Intrinsic Value_3Y_max--1.703--------
Intrinsic Value_3Y_min--1.088--------
Intrinsic Value_5Y_max--3.234--------
Intrinsic Value_5Y_min--1.921--------
Market Cap4427454280.320-43%6339424800.0006339424800.0000%10173508919.040-38%11807548912.408-46%9939643311.885-36%
Net Profit Margin--0.2740.2740%0.285-4%0.309-11%0.257+6%
Operating Margin--0.3050.3050%0.311-2%0.319-4%0.272+12%
Operating Ratio--1.0451.0450%1.033+1%0.973+7%0.743+41%
Pb Ratio1.662-43%2.3792.3790%4.474-47%6.442-63%6.524-64%
Pe Ratio8.874-43%12.70712.7070%25.498-50%36.714-65%37.820-66%
Price Per Share8.730-43%12.50012.5000%20.060-38%23.282-46%19.599-36%
Price To Free Cash Flow Ratio16.675-43%23.87623.8760%40.248-41%119.553-80%92.306-74%
Price To Total Gains Ratio8.333-43%11.93211.9320%27.234-56%31.097-62%31.722-62%
Quick Ratio--1.0491.0490%1.293-19%1.343-22%1.745-40%
Return On Assets--0.1360.1360%0.127+7%0.141-4%0.131+4%
Return On Equity--0.2010.2010%0.189+6%0.190+6%0.170+18%
Total Gains Per Share--1.0481.0480%0.737+42%0.794+32%0.719+46%
Usd Book Value--367980894.365367980894.3650%314043511.272+17%276407128.496+33%180258147.308+104%
Usd Book Value Change Per Share--0.1060.1060%0.074+45%0.083+29%0.079+34%
Usd Book Value Per Share--0.7260.7260%0.619+17%0.545+33%0.355+104%
Usd Dividend Per Share--0.0380.0380%0.028+36%0.027+41%0.020+93%
Usd Eps--0.1360.1360%0.109+25%0.098+39%0.064+111%
Usd Free Cash Flow--36667389.70936667389.7090%34907216.859+5%21198014.539+73%16737540.307+119%
Usd Free Cash Flow Per Share--0.0720.0720%0.069+5%0.042+73%0.033+119%
Usd Free Cash Flow To Equity Per Share--0.0600.0600%0.061-2%0.050+20%0.056+7%
Usd Market Cap611431436.112-43%875474564.880875474564.8800%1404961581.719-38%1630622504.804-46%1372664741.371-36%
Usd Price Per Share1.206-43%1.7261.7260%2.770-38%3.215-46%2.707-36%
Usd Profit--68899468.29368899468.2930%55100525.706+25%49492753.966+39%32595628.031+111%
Usd Revenue--251598963.105251598963.1050%193574961.463+30%165757018.615+52%110840616.019+127%
Usd Total Gains Per Share--0.1450.1450%0.102+42%0.110+32%0.099+46%
 EOD+4 -4MRQTTM+0 -0YOY+23 -125Y+23 -1210Y+27 -9

3.2. Fundamental Score

Let's check the fundamental score of Getein Biotech Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-158.874
Price to Book Ratio (EOD)Between0-11.662
Net Profit Margin (MRQ)Greater than00.274
Operating Margin (MRQ)Greater than00.305
Quick Ratio (MRQ)Greater than11.049
Current Ratio (MRQ)Greater than12.504
Debt to Asset Ratio (MRQ)Less than10.275
Debt to Equity Ratio (MRQ)Less than10.408
Return on Equity (MRQ)Greater than0.150.201
Return on Assets (MRQ)Greater than0.050.136
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Getein Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.439
Ma 20Greater thanMa 508.976
Ma 50Greater thanMa 1008.931
Ma 100Greater thanMa 2009.841
OpenGreater thanClose8.640
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,677,438
Total Liabilities1,012,841
Total Stockholder Equity2,482,468
 As reported
Total Liabilities 1,012,841
Total Stockholder Equity+ 2,482,468
Total Assets = 3,677,438

Assets

Total Assets3,677,438
Total Current Assets2,399,343
Long-term Assets1,278,095
Total Current Assets
Cash And Cash Equivalents 646,249
Short-term Investments 511,139
Net Receivables 494,044
Inventory 269,386
Other Current Assets 452,431
Total Current Assets  (as reported)2,399,343
Total Current Assets  (calculated)2,373,248
+/- 26,095
Long-term Assets
Property Plant Equipment 556,492
Goodwill 26,136
Intangible Assets 141,415
Other Assets 367,957
Long-term Assets  (as reported)1,278,095
Long-term Assets  (calculated)1,092,000
+/- 186,095

Liabilities & Shareholders' Equity

Total Current Liabilities958,063
Long-term Liabilities54,778
Total Stockholder Equity2,482,468
Total Current Liabilities
Short Long Term Debt 551,938
Accounts payable 121,381
Other Current Liabilities 177,856
Total Current Liabilities  (as reported)958,063
Total Current Liabilities  (calculated)851,175
+/- 106,888
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt4,652
Long-term Liabilities Other 911
Deferred Long Term Liability 51,049
Long-term Liabilities  (as reported)54,778
Long-term Liabilities  (calculated)56,612
+/- 1,834
Total Stockholder Equity
Common Stock507,154
Retained Earnings 1,655,377
Other Stockholders Equity 1,695
Total Stockholder Equity (as reported)2,482,468
Total Stockholder Equity (calculated)2,164,226
+/- 318,243
Other
Capital Stock507,154
Common Stock Shares Outstanding 507,154
Net Invested Capital 3,037,406
Net Tangible Assets 2,352,424
Net Working Capital 1,441,281
Property Plant and Equipment Gross 556,492



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312014-12-312013-12-312012-12-31
> Total Assets 
89,783
154,489
206,452
434,087
1,266,609
1,570,407
2,007,639
2,699,984
3,137,931
3,677,438
3,677,4383,137,9312,699,9842,007,6391,570,4071,266,609434,087206,452154,48989,783
   > Total Current Assets 
0
0
0
279,160
1,050,857
1,282,467
1,566,846
2,116,834
2,365,419
2,399,343
2,399,3432,365,4192,116,8341,566,8461,282,4671,050,857279,160000
       Cash And Cash Equivalents 
19,987
10,534
8,198
26,257
301,027
145,408
659,479
801,500
968,903
646,249
646,249968,903801,500659,479145,408301,02726,2578,19810,53419,987
       Short-term Investments 
0
0
0
167,080
634,140
0
467,355
594,923
612,677
511,139
511,139612,677594,923467,3550634,140167,080000
       Net Receivables 
9,747
20,977
16,226
26,202
37,551
92,642
247,841
456,703
438,762
494,044
494,044438,762456,703247,84192,64237,55126,20216,22620,9779,747
       Other Current Assets 
1,634
39,843
56,380
10,566
15,844
918,039
21,486
28,947
68,649
452,431
452,43168,64928,94721,486918,03915,84410,56656,38039,8431,634
   > Long-term Assets 
0
0
0
154,928
215,752
287,940
440,793
583,150
772,512
1,278,095
1,278,095772,512583,150440,793287,940215,752154,928000
       Property Plant Equipment 
38,179
56,424
69,649
122,488
174,867
231,350
296,752
369,627
452,205
556,492
556,492452,205369,627296,752231,350174,867122,48869,64956,42438,179
       Goodwill 
0
0
0
0
310
310
310
26,136
26,136
26,136
26,13626,13626,1363103103100000
       Intangible Assets 
4,389
8,516
10,260
25,216
25,549
29,814
37,057
80,611
105,372
141,415
141,415105,37280,61137,05729,81425,54925,21610,2608,5164,389
       Long-term Assets Other 
0
0
0
3,965
9,622
15,316
15,665
3,206
4,564
273,627
273,6274,5643,20615,66515,3169,6223,965000
> Total Liabilities 
49,153
70,424
41,259
91,126
118,874
187,228
325,984
695,946
863,902
1,012,841
1,012,841863,902695,946325,984187,228118,87491,12641,25970,42449,153
   > Total Current Liabilities 
48,918
69,898
39,304
85,260
111,729
179,996
316,885
656,608
813,482
958,063
958,063813,482656,608316,885179,996111,72985,26039,30469,89848,918
       Short-term Debt 
0
0
0
0
0
0
95,000
0
0
0
00095,000000000
       Short Long Term Debt 
0
0
0
0
0
0
95,000
364,789
464,366
551,938
551,938464,366364,78995,000000000
       Accounts payable 
27,274
44,314
10,520
3,855
9,663
22,718
55,580
95,906
123,767
121,381
121,381123,76795,90655,58022,7189,6633,85510,52044,31427,274
       Other Current Liabilities 
21,644
25,585
28,784
45,330
58,168
99,392
108,793
114,650
164,534
177,856
177,856164,534114,650108,79399,39258,16845,33028,78425,58521,644
   > Long-term Liabilities 
0
0
0
5,866
7,145
7,232
9,099
39,338
50,419
54,778
54,77850,41939,3389,0997,2327,1455,866000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-95,000
2,475
2,002
4,652
4,6522,0022,475-95,000000000
       Long-term Liabilities Other 
0
0
0
766
1,257
2,130
1,759
596
800
911
9118005961,7592,1301,257766000
       Deferred Long Term Liability 
0
0
0
2,243
2,925
5,817
12,822
34,479
43,676
51,049
51,04943,67634,47912,8225,8172,9252,243000
> Total Stockholder Equity
39,583
84,065
162,035
340,091
1,143,473
1,345,364
1,624,972
1,837,986
2,106,400
2,482,468
2,482,4682,106,4001,837,9861,624,9721,345,3641,143,473340,091162,03584,06539,583
   Common Stock
26,009
26,009
99,000
99,000
132,000
186,013
260,380
260,341
363,813
507,154
507,154363,813260,341260,380186,013132,00099,00099,00026,00926,009
   Retained Earnings 
13,574
58,056
10,699
181,123
315,111
504,923
773,223
973,804
1,279,633
1,655,377
1,655,3771,279,633973,804773,223504,923315,111181,12310,69958,05613,574
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
102
85
103
273
231
1,371
1,695
1,6951,37123127310385102000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,445,655
Cost of Revenue-523,508
Gross Profit922,147922,147
 
Operating Income (+$)
Gross Profit922,147
Operating Expense-1,202,424
Operating Income243,231-280,277
 
Operating Expense (+$)
Research Development231,978
Selling General Administrative390,717
Selling And Marketing Expenses-
Operating Expense1,202,424622,695
 
Net Interest Income (+$)
Interest Income5,223
Interest Expense-17,447
Other Finance Cost-35,687
Net Interest Income23,462
 
Pretax Income (+$)
Operating Income243,231
Net Interest Income23,462
Other Non-Operating Income Expenses-
Income Before Tax (EBT)269,566243,231
EBIT - interestExpense = -17,447
252,779
270,226
Interest Expense17,447
Earnings Before Interest and Taxes (EBIT)-287,014
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax269,566
Tax Provision-13,030
Net Income From Continuing Ops256,536256,536
Net Income252,779
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--23,462
 

Technical Analysis of Getein
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Getein. The general trend of Getein is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Getein's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Getein Biotech Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8.79 < 9.5 < 9.56.

The bearish price targets are: 8.14 > 7.44.

Tweet this
Getein Biotech Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Getein Biotech Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Getein Biotech Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Getein Biotech Inc. The current macd is -0.14175834.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Getein price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Getein. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Getein price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Getein Biotech Inc Daily Moving Average Convergence/Divergence (MACD) ChartGetein Biotech Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Getein Biotech Inc. The current adx is 19.64.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Getein shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Getein Biotech Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Getein Biotech Inc. The current sar is 9.40279636.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Getein Biotech Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Getein Biotech Inc. The current rsi is 45.44. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Getein Biotech Inc Daily Relative Strength Index (RSI) ChartGetein Biotech Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Getein Biotech Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Getein price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Getein Biotech Inc Daily Stochastic Oscillator ChartGetein Biotech Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Getein Biotech Inc. The current cci is -70.96920011.

Getein Biotech Inc Daily Commodity Channel Index (CCI) ChartGetein Biotech Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Getein Biotech Inc. The current cmo is -8.96647264.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Getein Biotech Inc Daily Chande Momentum Oscillator (CMO) ChartGetein Biotech Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Getein Biotech Inc. The current willr is -56.61764706.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Getein is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Getein Biotech Inc Daily Williams %R ChartGetein Biotech Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Getein Biotech Inc.

Getein Biotech Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Getein Biotech Inc. The current atr is 0.33712502.

Getein Biotech Inc Daily Average True Range (ATR) ChartGetein Biotech Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Getein Biotech Inc. The current obv is -1,098,335.

Getein Biotech Inc Daily On-Balance Volume (OBV) ChartGetein Biotech Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Getein Biotech Inc. The current mfi is 47.94.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Getein Biotech Inc Daily Money Flow Index (MFI) ChartGetein Biotech Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Getein Biotech Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Getein Biotech Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Getein Biotech Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.439
Ma 20Greater thanMa 508.976
Ma 50Greater thanMa 1008.931
Ma 100Greater thanMa 2009.841
OpenGreater thanClose8.640
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Getein with someone you think should read this too:
  • Are you bullish or bearish on Getein? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Getein? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Getein Biotech Inc

I send you an email if I find something interesting about Getein Biotech Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Getein Biotech Inc.

Receive notifications about Getein Biotech Inc in your mailbox!